# Indonesia Investment authority

> Indonesia Investment authority is a VC fund backing Pharmaceutical. See 10 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Jakarta, Indonesia
- Total investments: 10
- Last investment: Jun 2026
- Lead investor: 30%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/indonesia-investment-authority
- Website: https://www.ina.go.id/en

Indonesia Investment authority is a VC fund in Jakarta focused on Pharmaceutical and Chemical. Indonesia Investment Authority is Indonesia’s sovereign wealth fund. through investment funds, INA builds wealth for future generations and contribute to Indonesia’s sustainable economic development.

## Contacts

5 contacts available for Indonesia Investment authority. Shizune tracks 3 team members at Indonesia Investment authority. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/indonesia-investment-authority?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Pharmaceutical | 3 | 30% |
| Chemical | 2 | 20% |
| Health Care | 2 | 20% |
| Retail | 1 | 10% |
| Travel | 1 | 10% |

19 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Funding Round | 3 | 30% |
| Venture - Series Unknown | 3 | 30% |
| Series C | 1 | 10% |
| Debt Financing | 1 | 10% |
| Post-IPO Equity | 1 | 10% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Indonesia | 5 | 50% |
| Singapore | 1 | 10% |
| South Korea | 1 | 10% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Andry Setiawan | Co-Chief Investment Officer | 0 | — |
| Christopher Ganis | CO-Chief Investment Officer | 0 | — |
| Eddy Porwanto | Chief Financial Officer; Acting Chief Executive Officer | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| DayOne | GDS International portfolio currently comprises approximately 480 MW of data center capacity in service and under construction and an additional 590 MW held for future development across strategic locations in Hong Kong, Singapore, Malaysia (Johor), Indonesia (Batam), and Japan (Tokyo). | $2.5B | Series C | Jun 05, 2026 |  |
| PT Chandra Asri Alkali | PT Chandra Asri Alkali (CAA) is a subsidiary of PT Chandra Asri Pacific Tbk, Indonesia's petrochemical company. | $800M |  | Mar 03, 2026 |  |
| DayOne | GDS International portfolio currently comprises approximately 480 MW of data center capacity in service and under construction and an additional 590 MW held for future development across strategic locations in Hong Kong, Singapore, Malaysia (Johor), Indonesia (Batam), and Japan (Tokyo). | $2B | Series C | Jan 05, 2026 |  |
| SK Plasma Core Indonesia | SK Plasma Core Indonesia is a joint venture between SK Plasma and Indonesia Investment Authority. |  |  | Nov 14, 2024 |  |
| PT Pertamina Bina Medika | PT Pertamina Bina Medika offers various healthcare services that cover MRI, MCU, CT Scan, home care services, vaccination, and cardiology. |  |  | Dec 23, 2023 |  |
| SK Plasma | The plasma-derivatives business of SK chemicals has earned a remarkable reputation recently and has achieved strong growth in the export market as well. SK Plasma was established in order to focus on the core competence of plasma-derivatives and to provide customers with higher quality products and services. | $49.8M | Venture - Series Unknown | Oct 10, 2023 |  |
| Belawan New Container Terminal | Website Coverage Q3 2025 - not found Website not found Q4 2025 | $400M | Venture - Series Unknown | Jun 23, 2023 |  |
| Kimia Farma Apotek | Kimia Farma Apotek is a retail-chain pharmaceutical company providing pharmaceutical solutions and healthcare solutions ranging from prescription drugs, nonprescription drugs, traditional medicines, medical equipment, diet and nutrition, vitamins, minerals and supplements, baby and child necessities, personal care to beauty products. | $119.2M | Venture - Series Unknown | Nov 13, 2022 |  |
| Kimia Farma | Kimia Farma is a pioneer in Indonesian pharmaceutical industry. The embryo of the company could be traced back to 1917, when NV Chemicalien Handle Rathkamp & Co., the first pharmaceutical company in the East Indies, was founded. In line with the nationalization policy of former Dutch companies, in 1958 the government merged a number ofpharmaceutical companies into PNF Bhinneka Kimia Farma. Subsequently on 16 August 1971 the legal form was changed to Limited Liability Company, PT Kimia Farma (Persero). Since July 4, 2001 Kimia Farma is listed as a public company on the Jakarta Stock Exchange and Surabaya Stock Exchange. Armed with a long industry tradition for over 187 years and a name synonymous with quality, | $119.2M | Post-IPO Equity | Nov 13, 2022 |  |
| Traveloka | Traveloka is an online travel aggregator that helps customers choose and book their next travel location.Traveloka is an Indonesian flight search engine covering mostly domestic routes and airlines. The company is is expanding its reach by operating in six countries and experimenting with new endeavors that will create large impact in the marketsand industries they touch. | $300M | Debt Financing | Sep 29, 2022 |  |

10 of 10 investments shown.

## Co-investors
- [Coatue](https://shizune.co/investors/profile/coatue) — VC Fund, 2 deals together
- Silk Road Fund — VC Fund, 2 deals together
- Achi Capital Partners — VC Fund, 1 deal together
- [Allianz Global Investors](https://shizune.co/investors/profile/allianz-global-investors) — VC Fund, 1 deal together
- [BlackRock](https://shizune.co/investors/profile/blackrock) — VC Fund, 1 deal together
- Chandra Asri — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund

## FAQ

### What does Indonesia Investment authority invest in?

Indonesia Investment authority invests primarily in Pharmaceutical, Chemical and Health Care startups, most often at Funding Round and Venture - Series Unknown stage. Most of the 10 investments tracked by Shizune back companies in Indonesia. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Indonesia Investment authority?

Public channels for Indonesia Investment authority include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Indonesia Investment authority?

The team at Indonesia Investment authority includes Andry Setiawan (Co-Chief Investment Officer), Christopher Ganis (CO-Chief Investment Officer) and Eddy Porwanto (Chief Financial Officer; Acting Chief Executive Officer). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co